个人中心 - 老虎社区

AndrewGoh

AndrewGoh

IP属地：未知

帖子 · 8帖子 · 8
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- AndrewGohAndrewGoh
  ·2021-12-06
  😢
  外媒头条：高盛最新预测！再度下调美国GDP预期
  全球财经媒体昨夜今晨共同关注的头条新闻主要有： 1、高盛下调美国今明两年GDP的预期因奥密克戎可能拖累经济增长 2、投资者权衡omicron和美联储下一步行动，股市或会出现更多动荡 3、马
  外媒头条：高盛最新预测！再度下调美国GDP预期
  1,258 评论
  3
  分享
  举报
- AndrewGohAndrewGoh
  ·2021-11-08
  Great ariticle, would you like to share it?
  US to Opec+: ‘This isn’t the end’ of effort to ease oil prices
  Biden wants the cartel to pump more oil to bring down prices and keep the post-Covid economic recovery on course
  US to Opec+: ‘This isn’t the end’ of effort to ease oil prices
  674 评论
  1
  分享
  举报
- AndrewGohAndrewGoh
  ·2021-08-10
  Like pls
  Stocks making the biggest moves in the premarket: Casper Sleep, AMC Entertainment, 3D Systems and more
  Casper Sleep Inc. – The sleep products company reported record quarterly revenue that came in above
  Stocks making the biggest moves in the premarket: Casper Sleep, AMC Entertainment, 3D Systems and more
  377 评论
  1
  分享
  举报
- AndrewGohAndrewGoh
  ·2021-08-08
  Like pls
  非常抱歉，此主贴已删除
  785 评论
  点赞
  分享
  举报
- AndrewGohAndrewGoh
  ·2021-08-06
  Wow
  Warren Buffett’s Berkshire Hathaway Is Reporting Earnings on Saturday. Here’s What to Expect.
  Berkshire Hathaway is expected to report strong second-quarter results on Saturday, including a 7% r
  Warren Buffett’s Berkshire Hathaway Is Reporting Earnings on Saturday. Here’s What to Expect.
  595 评论
  点赞
  分享
  举报
- AndrewGohAndrewGoh
  ·2021-08-04
  Wow
  非常抱歉，此主贴已删除
  807 评论
  点赞
  分享
  举报
- AndrewGohAndrewGoh
  ·2021-08-04
  Up up up
  非常抱歉，此主贴已删除
  606 评论
  点赞
  分享
  举报
- AndrewGohAndrewGoh
  ·2021-08-04
  💪🏾
  3 COVID Stocks That Could Soar Higher
  Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021. Key Points Pfi
  3 COVID Stocks That Could Soar Higher
  629 评论
  1
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3584848686759477","uuid":"3584848686759477","gmtCreate":1621756417032,"gmtModify":1621758805829,"name":"AndrewGoh","pinyin":"andrewgoh","introduction":"","introductionEn":"","signature":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":286,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.27","exceedPercentage":"60.88%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":608504888,"gmtCreate":1638755064078,"gmtModify":1638755064078,"author":{"id":"3584848686759477","authorId":"3584848686759477","name":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584848686759477","authorIdStr":"3584848686759477"},"themes":[],"htmlText":"😢","listText":"😢","text":"😢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608504888","repostId":"2189278574","repostType":2,"repost":{"id":"2189278574","kind":"news","pubTimestamp":1638740160,"share":"https://www.laohu8.com/m/news/2189278574?lang=&edition=full","pubTime":"2021-12-06 05:36","market":"us","language":"zh","title":"外媒头条：高盛最新预测！再度下调美国GDP预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2189278574","media":"新浪财经","summary":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、高盛下调美国今明两年GDP的预期 因奥密克戎可能拖累经济增长\n\n\n2、投资者权衡omicron和美联储下一步行动，股市或会出现更多动荡\n\n\n3、马","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p>\n<blockquote>\n <b>1、<a href=\"https://laohu8.com/S/GS\">高盛</a>下调美国今明两年GDP的预期 因奥密克戎可能拖累经济增长</b>\n</blockquote>\n<blockquote>\n <b>2、投资者权衡omicron和美联储下一步行动，股市或会出现更多动荡</b>\n</blockquote>\n<blockquote>\n <b>3、马斯克已卖掉最后房产 正式成为“无家可归者”</b>\n</blockquote>\n<blockquote>\n <b>4、Spotify涉版权纠纷 撤下众多喜剧演员作品</b>\n</blockquote>\n<blockquote>\n <b>5、加拿大劳动力市场短缺加剧 雇主准备接纳未接种疫苗者</b>\n</blockquote>\n<blockquote>\n <b>6、美国疾控中心负责人：至少15个州Omicron变体感染病例会增加</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/cec3c4f2f288cc445838fa72cf9da487\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\"></p>\n<p><b>高盛下调美国今明两年GDP的预期 因奥密克戎可能拖累经济增长</b></p>\n<p>高盛集团经济学家认为，奥密克戎变异毒株的传播将对美国经济增长形成“温和拖累”，因此下调今明两年美国经济预期。</p>\n<p>高盛经济学家Joseph Briggs在一份周末致客户的报告中指出，现预计美国今年GDP增长3.8%，之前预期为增长4.2%。2022年的预期从3.3%下调至2.9%。</p>\n<p>“虽然许多问题仍然没有答案，我们现在认为最有可能的情况是病毒会更快传播，但对抗重症的免疫力只会略微减弱，从而构成温和下行的情景，”Briggs表示。</p>\n<p>他指出，奥密克戎可能只会对服务业支出构成温和影响，并可能加剧供应短缺。同时，也可能推迟一些人愿意返回工作岗位的时间。</p>\n<p><img src=\"https://static.tigerbbs.com/7ac404fb99923391b77413f803dd05a5\" tg-width=\"550\" tg-height=\"366\" referrerpolicy=\"no-referrer\"></p>\n<p><b>投资者权衡omicron和美联储下一步行动，股市或会出现更多动荡</b></p>\n<p>在经历了一周的剧烈震荡导致许多股票暴跌之后，波动性可能会继续困扰市场。</p>\n<p>在接下来的一周中，投资者将等待有关 omicron 变体的更多消息以及周五的另一份通胀报告，预计该报告显示的消费者价格仍然是 30 年来最热的。</p>\n<p>过去一周，由于担心 omicron 变体以及担心美联储将放弃其宽松政策并比预期更早地加息，股票遭到抛售。美联储主席杰罗姆鲍威尔周二对国会小组表示，美联储将在 12 月 14 日和 15 日开会时考虑加快缩减每月 1200 亿美元的债券购买计划。美联储提前实施了债券购买计划2020年在大流行期间支撑经济。</p>\n<p>Cresset 首席投资官杰克·阿布林 （Jack Ablin） 表示：“这将是一个有点动荡的 12 月，因为我们可能需要等待财报季重新回归，回到基本面。”鲍威尔的言论令投资者感到不安，他们担心美联储也会加快加息步伐。</p>\n<p><img src=\"https://static.tigerbbs.com/d7f8a47eb6766ada2b13bdfdf2d40639\" tg-width=\"550\" tg-height=\"413\" referrerpolicy=\"no-referrer\"></p>\n<p><b>马斯克已卖掉最后房产 正式成为“无家可归者”</b></p>\n<p>12月5日消息，据外媒报道，作为世界首富，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>和SpaceX首席执行官埃隆·马斯克（Elon Musk）兑现了“没有任何房产”的承诺。他刚刚以3000万美元的价格将位于硅谷的豪宅卖出，加入“无家可归者”行列。</p>\n<p>马斯克以3000万美元的价格出售了他在硅谷的房产，这是他在加州七套房子中的最后一套，并搬到了得克萨斯州</p>\n<p>这套住宅位于加州希尔斯伯勒水晶泉路891号，占地超过19万平方米。马斯克曾说过，这里是他“地球上的最后房产”。</p>\n<p>现在，马斯克以3000万美元将其出售，与6月份首次挂牌时的3750万美元相比，价格整整下降了750万美元。这栋住宅出售经历了多次波折，在找到最后买家之前，曾先后三次挂牌。</p>\n<p><img src=\"https://static.tigerbbs.com/c2308e4896f97d6b4a7264b28ee7c49a\" tg-width=\"550\" tg-height=\"290\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Spotify涉版权纠纷 撤下众多喜剧演员作品</b></p>\n<p>由于版权费和版权纠纷，Spotify从其流媒体平台上撤下了数百名喜剧演员的专辑和作品。</p>\n<p>据悉，一家全球版权管理公司 Spoken Giants 正在与一群知名喜剧演员合作，协助后者跟互联网平台进行交涉，使得他们的作品在 Spotify、SiriusXM、Pandora 和 YouTube 等平台上需要付费观看时也能获得相应的版权费用。Spotify 随后删除了 Tiffany Haddish、Jim Gaffigan、Kevin Hart 和 John Mulaney 等众多喜剧表演者的作品。</p>\n<p>据报道，喜剧演员的目标是为“口语媒体的基本作曲版权”收取版税，类似于歌曲作者为他们的音乐和歌词获得报酬的方式。</p>\n<p>当双方谈判陷入僵局时，Spotify 将喜剧演员的作品从其流媒体平台上撤下。</p>\n<p><b>加拿大劳动力市场短缺加剧 雇主准备接纳未接种疫苗者</b></p>\n<p>加拿大紧张的劳动力市场迫使许多公司不得不在接种疫苗要求之外提供定期的核酸检测的替代途径，而其他一些公司则在改变先前宣布的接种疫苗要求，即使 Omicron 变异病例正在增加。</p>\n<p>加拿大政府采取了世界上最严格的公务员接种政策之一。航空公司、警察部队、学校董事会甚至加拿大的五大银行也承诺实施严格的强制性疫苗政策。但事实证明，坚持下去并不那么简单，尤其是在雇主努力应对人员短缺和工人要求豁免的情况下。</p>\n<p>官方数据显示，今年迄今为止，加拿大的职位空缺增加了一倍，而疫苗规定可能会使填补这些职位变得更加困难，从而可能给工资带来上涨压力。这可能会加剧已经达到近两年高位的通胀。</p>\n<p>雇用未接种疫苗的人存在缺陷。行业团体和营销专家表示，公司面临更高的新冠肺炎爆发风险，许多接种疫苗的员工对与未接种疫苗的员工一起工作感到不舒服。</p>\n<p><img src=\"https://static.tigerbbs.com/77bdbbe01292979d27bad87d5c6416ec\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国疾控中心负责人：至少15个州Omicron变体感染病例会增加</b></p>\n<p>美国疾病控制与预防中心主任罗谢尔·瓦伦斯基 （Rochelle Walensky） 表示 ，至少有 15 个州检测到了 omicron 变体，预计这一数字还会上升。</p>\n<p>“我们知道我们有几十个案例，我们正在密切关注它们。我们每天都听到越来越多的可能病例，因此这个数字可能会上升，”瓦伦斯基说。</p>\n<p>这种变种最初在南非发现，它的刺突蛋白有几个突变，允许病毒进入人体，其中一些突变可能导致其传播能力增加。科学家们仍在收集有关该病毒和当前新冠疫苗是否有效的数据。</p>\n<p>在其他几个国家被发现后，美国于 12 月 1 日报告了首例 omicron 病例。虽然一些患者最近去过南部非洲，但其他人没有旅行史。这表明社区传播正在进行中。</p>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：高盛最新预测！再度下调美国GDP预期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：高盛最新预测！再度下调美国GDP预期\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-06 05:36 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-12-06/doc-ikyamrmy7072307.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、高盛下调美国今明两年GDP的预期 因奥密克戎可能拖累经济增长\n\n\n2、投资者权衡omicron和美联储下一步行动，股市或会出现更多动荡\n\n\n3、马斯克已卖掉最后房产 正式成为“无家可归者”\n\n\n4、Spotify涉版权纠纷 撤下众多喜剧演员作品\n\n\n5、加拿大劳动力市场短缺加剧 雇主准备接纳未接种疫苗者\n\n\n6、美国疾控中心负责人：至少15个州...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-12-06/doc-ikyamrmy7072307.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/cec3c4f2f288cc445838fa72cf9da487","relate_stocks":{"161125":"标普500","513500":"标普500ETF","PSQ":"纳指反向ETF","TQQQ":"纳指三倍做多ETF","OEF":"标普100指数ETF-iShares","TSLA":"特斯拉",".SPX":"S&P 500 Index","DJX":"1/100道琼斯","UDOW":"道指三倍做多ETF-ProShares","DDM":"道指两倍做多ETF","BK4534":"瑞士信贷持仓","BK4555":"新能源车","BK4533":"AQR资本管理(全球第二大对冲基金)","QID":"纳指两倍做空ETF","SDOW":"道指三倍做空ETF-ProShares",".DJI":"道琼斯","SPXU":"三倍做空标普500ETF","DOG":"道指反向ETF",".IXIC":"NASDAQ Composite","UPRO":"三倍做多标普500ETF","DXD":"道指两倍做空ETF","OEX":"标普100","BK4527":"明星科技股","QQQ":"纳指100ETF","BK4559":"巴菲特持仓","SDS":"两倍做空标普500ETF","BK4550":"红杉资本持仓","SPY":"标普500ETF","SQQQ":"纳指三倍做空ETF","SH":"标普500反向ETF","BK4551":"寇图资本持仓","SSO":"两倍做多标普500ETF","QLD":"纳指两倍做多ETF","BK4504":"桥水持仓","IVV":"标普500指数ETF","BK4099":"汽车制造商","BK4548":"巴美列捷福持仓"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-12-06/doc-ikyamrmy7072307.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2189278574","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、高盛下调美国今明两年GDP的预期 因奥密克戎可能拖累经济增长\n\n\n2、投资者权衡omicron和美联储下一步行动，股市或会出现更多动荡\n\n\n3、马斯克已卖掉最后房产 正式成为“无家可归者”\n\n\n4、Spotify涉版权纠纷 撤下众多喜剧演员作品\n\n\n5、加拿大劳动力市场短缺加剧 雇主准备接纳未接种疫苗者\n\n\n6、美国疾控中心负责人：至少15个州Omicron变体感染病例会增加\n\n\n高盛下调美国今明两年GDP的预期 因奥密克戎可能拖累经济增长\n高盛集团经济学家认为，奥密克戎变异毒株的传播将对美国经济增长形成“温和拖累”，因此下调今明两年美国经济预期。\n高盛经济学家Joseph Briggs在一份周末致客户的报告中指出，现预计美国今年GDP增长3.8%，之前预期为增长4.2%。2022年的预期从3.3%下调至2.9%。\n“虽然许多问题仍然没有答案，我们现在认为最有可能的情况是病毒会更快传播，但对抗重症的免疫力只会略微减弱，从而构成温和下行的情景，”Briggs表示。\n他指出，奥密克戎可能只会对服务业支出构成温和影响，并可能加剧供应短缺。同时，也可能推迟一些人愿意返回工作岗位的时间。\n\n投资者权衡omicron和美联储下一步行动，股市或会出现更多动荡\n在经历了一周的剧烈震荡导致许多股票暴跌之后，波动性可能会继续困扰市场。\n在接下来的一周中，投资者将等待有关 omicron 变体的更多消息以及周五的另一份通胀报告，预计该报告显示的消费者价格仍然是 30 年来最热的。\n过去一周，由于担心 omicron 变体以及担心美联储将放弃其宽松政策并比预期更早地加息，股票遭到抛售。美联储主席杰罗姆鲍威尔周二对国会小组表示，美联储将在 12 月 14 日和 15 日开会时考虑加快缩减每月 1200 亿美元的债券购买计划。美联储提前实施了债券购买计划2020年在大流行期间支撑经济。\nCresset 首席投资官杰克·阿布林 （Jack Ablin） 表示：“这将是一个有点动荡的 12 月，因为我们可能需要等待财报季重新回归，回到基本面。”鲍威尔的言论令投资者感到不安，他们担心美联储也会加快加息步伐。\n\n马斯克已卖掉最后房产 正式成为“无家可归者”\n12月5日消息，据外媒报道，作为世界首富，特斯拉和SpaceX首席执行官埃隆·马斯克（Elon Musk）兑现了“没有任何房产”的承诺。他刚刚以3000万美元的价格将位于硅谷的豪宅卖出，加入“无家可归者”行列。\n马斯克以3000万美元的价格出售了他在硅谷的房产，这是他在加州七套房子中的最后一套，并搬到了得克萨斯州\n这套住宅位于加州希尔斯伯勒水晶泉路891号，占地超过19万平方米。马斯克曾说过，这里是他“地球上的最后房产”。\n现在，马斯克以3000万美元将其出售，与6月份首次挂牌时的3750万美元相比，价格整整下降了750万美元。这栋住宅出售经历了多次波折，在找到最后买家之前，曾先后三次挂牌。\n\nSpotify涉版权纠纷 撤下众多喜剧演员作品\n由于版权费和版权纠纷，Spotify从其流媒体平台上撤下了数百名喜剧演员的专辑和作品。\n据悉，一家全球版权管理公司 Spoken Giants 正在与一群知名喜剧演员合作，协助后者跟互联网平台进行交涉，使得他们的作品在 Spotify、SiriusXM、Pandora 和 YouTube 等平台上需要付费观看时也能获得相应的版权费用。Spotify 随后删除了 Tiffany Haddish、Jim Gaffigan、Kevin Hart 和 John Mulaney 等众多喜剧表演者的作品。\n据报道，喜剧演员的目标是为“口语媒体的基本作曲版权”收取版税，类似于歌曲作者为他们的音乐和歌词获得报酬的方式。\n当双方谈判陷入僵局时，Spotify 将喜剧演员的作品从其流媒体平台上撤下。\n加拿大劳动力市场短缺加剧 雇主准备接纳未接种疫苗者\n加拿大紧张的劳动力市场迫使许多公司不得不在接种疫苗要求之外提供定期的核酸检测的替代途径，而其他一些公司则在改变先前宣布的接种疫苗要求，即使 Omicron 变异病例正在增加。\n加拿大政府采取了世界上最严格的公务员接种政策之一。航空公司、警察部队、学校董事会甚至加拿大的五大银行也承诺实施严格的强制性疫苗政策。但事实证明，坚持下去并不那么简单，尤其是在雇主努力应对人员短缺和工人要求豁免的情况下。\n官方数据显示，今年迄今为止，加拿大的职位空缺增加了一倍，而疫苗规定可能会使填补这些职位变得更加困难，从而可能给工资带来上涨压力。这可能会加剧已经达到近两年高位的通胀。\n雇用未接种疫苗的人存在缺陷。行业团体和营销专家表示，公司面临更高的新冠肺炎爆发风险，许多接种疫苗的员工对与未接种疫苗的员工一起工作感到不舒服。\n\n美国疾控中心负责人：至少15个州Omicron变体感染病例会增加\n美国疾病控制与预防中心主任罗谢尔·瓦伦斯基 （Rochelle Walensky） 表示 ，至少有 15 个州检测到了 omicron 变体，预计这一数字还会上升。\n“我们知道我们有几十个案例，我们正在密切关注它们。我们每天都听到越来越多的可能病例，因此这个数字可能会上升，”瓦伦斯基说。\n这种变种最初在南非发现，它的刺突蛋白有几个突变，允许病毒进入人体，其中一些突变可能导致其传播能力增加。科学家们仍在收集有关该病毒和当前新冠疫苗是否有效的数据。\n在其他几个国家被发现后，美国于 12 月 1 日报告了首例 omicron 病例。虽然一些患者最近去过南部非洲，但其他人没有旅行史。这表明社区传播正在进行中。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845166945,"gmtCreate":1636306628065,"gmtModify":1636306628153,"author":{"id":"3584848686759477","authorId":"3584848686759477","name":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584848686759477","authorIdStr":"3584848686759477"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845166945","repostId":"2181409167","repostType":4,"repost":{"id":"2181409167","kind":"news","pubTimestamp":1636262820,"share":"https://www.laohu8.com/m/news/2181409167?lang=&edition=full","pubTime":"2021-11-07 13:27","market":"fut","language":"en","title":"US to Opec+: ‘This isn’t the end’ of effort to ease oil prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2181409167","media":"BusinessDay","summary":"Biden wants the cartel to pump more oil to bring down prices and keep the post-Covid economic recovery on course","content":"<div>\n<p>The US warned this week that Opec+ is at risk of impairing the world’s economic recovery by failing to put more oil into the global market, signalling that its efforts to ease high crude prices aren’t...</p>\n\n<a href=\"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/\">Web Link</a>\n\n</div>\n","source":"businessday_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US to Opec+: ‘This isn’t the end’ of effort to ease oil prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS to Opec+: ‘This isn’t the end’ of effort to ease oil prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-07 13:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/><strong>BusinessDay</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The US warned this week that Opec+ is at risk of impairing the world’s economic recovery by failing to put more oil into the global market, signalling that its efforts to ease high crude prices aren’t...</p>\n\n<a href=\"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.businesslive.co.za/bt/business-and-economy/2021-11-07-us-to-opec-this-isnt-the-end-of-effort-to-ease-oil-prices/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181409167","content_text":"The US warned this week that Opec+ is at risk of impairing the world’s economic recovery by failing to put more oil into the global market, signalling that its efforts to ease high crude prices aren’t over.Hours after Saudi Arabia and its allies in Opec+ — the 14 members of the Organisation of Petroleum Exporting Countries plus 10 non-members, including Russia — approved a 400,000 barrel-a-day output hike for December, the White House reiterated that it will consider “the full range of tools” to protect the economy.Other major consumers also say the Opec+ decision, at a meeting of the cartel this week, is not enough to sustain the post-Covid economic recovery, with the US asking for as much as double that amount. “They have the capacity and the power now to act and make sure this critical moment of global recovery is not impaired,” White House spokesperson Karine Jean-Pierre said.The US operates in “a competitive free market system”, she said, and Opec+ “is what impacts global oil prices, which is what has an effect on gas [petrol] prices at home”.","news_type":1},"isVote":1,"tweetType":1,"viewCount":674,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":896118141,"gmtCreate":1628561179583,"gmtModify":1633746148173,"author":{"id":"3584848686759477","authorId":"3584848686759477","name":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584848686759477","authorIdStr":"3584848686759477"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/896118141","repostId":"1196813173","repostType":4,"repost":{"id":"1196813173","kind":"news","pubTimestamp":1628550902,"share":"https://www.laohu8.com/m/news/1196813173?lang=&edition=full","pubTime":"2021-08-10 07:15","market":"us","language":"en","title":"Stocks making the biggest moves in the premarket: Casper Sleep, AMC Entertainment, 3D Systems and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1196813173","media":"CNBC","summary":"Casper Sleep Inc. – The sleep products company reported record quarterly revenue that came in above ","content":"<div>\n<p>Casper Sleep Inc. – The sleep products company reported record quarterly revenue that came in above Street forecasts, though it still reported a quarterly loss. Casper Sleep said it saw strong growth ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/10/stocks-making-the-biggest-moves-in-the-premarket-casper-sleep-amc-entertainment-3d-systems-and-more.html?&qsearchterm=biggest%20moves\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves in the premarket: Casper Sleep, AMC Entertainment, 3D Systems and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves in the premarket: Casper Sleep, AMC Entertainment, 3D Systems and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 07:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/08/10/stocks-making-the-biggest-moves-in-the-premarket-casper-sleep-amc-entertainment-3d-systems-and-more.html?&qsearchterm=biggest%20moves><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Casper Sleep Inc. – The sleep products company reported record quarterly revenue that came in above Street forecasts, though it still reported a quarterly loss. Casper Sleep said it saw strong growth ...</p>\n\n<a href=\"https://www.cnbc.com/2021/08/10/stocks-making-the-biggest-moves-in-the-premarket-casper-sleep-amc-entertainment-3d-systems-and-more.html?&qsearchterm=biggest%20moves\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IHG":"洲际酒店","PLNT":"Planet Fitness Inc","ARMK":"Aramark","IIVI":"COHERENT CORP 6.00% MANDATORY CON PFD SER A","AMC":"AMC院线","KSU":"堪萨斯南方铁路","CHGG":"Chegg Inc","DDD":"3D系统"},"source_url":"https://www.cnbc.com/2021/08/10/stocks-making-the-biggest-moves-in-the-premarket-casper-sleep-amc-entertainment-3d-systems-and-more.html?&qsearchterm=biggest%20moves","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1196813173","content_text":"Casper Sleep Inc. – The sleep products company reported record quarterly revenue that came in above Street forecasts, though it still reported a quarterly loss. Casper Sleep said it saw strong growth in both retail and direct-to-consumer sales channels, but noted that it is also dealing with higher input costs and supply chain difficulties. Shares initially rallied in the premarket, but subsequently tumbled 6.1%.\nAMC Entertainment – AMC reported a quarterly loss of 71 cents per share, 20 cents a share smaller than Wall Street had anticipated. Revenue came in above analysts’ forecasts. AMC was helped by the lifting of Covid restrictions and the return of moviegoers to theaters, along with the release of several hit movies. Its shares surged 7.8% in premarket action.\n3D – 3D Systems earned 12 cents per share for its latest quarter, beating the 5 cents a share consensus estimate. The 3D printing technology company’s revenue beat estimates as well. 3D said it had successfully come through the most challenging 12 months it had ever experienced amid the pandemic. 3D’s stock soared 14.1% in premarket action.\nKansas City Southern –Canadian Pacific Railway(CP) raised its cash-and-stock offer for Kansas City Southern to about $300 per share. Canadian Pacific had struck a deal to buy its rival rail operator for $275 per share, but Kansas City Southern subsequently agreed to a higher offer fromCanadian National Railway(CNI). Kansas City Southern surged 7.2% in the premarket, while Canadian Pacific lost 1.7% and Canadian National rose 1.9%.\nAramark – The foodservice company reported a quarterly profit of 3 cents per share, beating the penny a share consensus estimate. Revenue came in slightly below forecasts. Aramark said it benefited from rebounding sales volume as well as effective cost management. Aramark shares added 1.3% in the premarket.\nPlanet Fitness – Planet Fitness missed estimates by 2 cents a share, with quarterly earnings of 21 cents per share. Revenue topped estimates as gyms reopened and membership numbers increased for the fitness center operator. Shares fell 3.2% in the premarket.\nThe RealReal – The RealReal lost 50 cents per share for its latest quarter, 3 cents a share wider than analysts had anticipated. The operator of an online pre-owned luxury goods marketplace also saw revenue fall short of estimates. The company said gross merchandise volume was up 91% compared to a year ago, and up 84.5% from repeat buyers. The stock slid 6% in premarket trading.\nChegg – Chegg beat estimates by 6 cents a share, with quarterly earnings of 43 cents per share. The online education company’s revenue also topped forecasts. Chegg raised its full-year outlook, saying its international growth continues to be strong. Its shares added 2.9% in the premarket.\nInterContinental Hotels Group PLC – InterContinental Hotels reported an operating profit for the first six months of the year, rebounding from a year-ago loss as summer vacation bookings jumped. The operator of Holiday Inn and other hotel chains eliminated its dividend to cut costs, however, sending its shares down 1.6% in premarket trading.\nII-VI Inc – The maker of optoelectronic components beat estimates on the top and bottom lines for its latest quarter, earning 88 cents per share compared to a 76 cents a share consensus estimate. It also had its highest-ever backlog at the end of the quarter.","news_type":1},"isVote":1,"tweetType":1,"viewCount":377,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891548003,"gmtCreate":1628403709602,"gmtModify":1633747308516,"author":{"id":"3584848686759477","authorId":"3584848686759477","name":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584848686759477","authorIdStr":"3584848686759477"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/891548003","repostId":"1190347839","repostType":4,"isVote":1,"tweetType":1,"viewCount":785,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893050248,"gmtCreate":1628223188984,"gmtModify":1633752440975,"author":{"id":"3584848686759477","authorId":"3584848686759477","name":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584848686759477","authorIdStr":"3584848686759477"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/893050248","repostId":"1196684672","repostType":4,"repost":{"id":"1196684672","kind":"news","pubTimestamp":1628221912,"share":"https://www.laohu8.com/m/news/1196684672?lang=&edition=full","pubTime":"2021-08-06 11:51","market":"us","language":"en","title":"Warren Buffett’s Berkshire Hathaway Is Reporting Earnings on Saturday. Here’s What to Expect.","url":"https://stock-news.laohu8.com/highlight/detail?id=1196684672","media":"Barrons","summary":"Berkshire Hathaway is expected to report strong second-quarter results on Saturday, including a 7% r","content":"<p>Berkshire Hathaway is expected to report strong second-quarter results on Saturday, including a 7% rise in its book value and a 10% increase in operating earnings.</p>\n<p>Berkshire (ticker: BRK.A and BRK.B) likely benefited in the second quarter from a 10% gain in the value of its roughly $300 billion equity portfolio, with about half that appreciation driven by a 12% increase in the share price of Apple (AAPL), Berkshire’s largest equity holding at more than $120 billion.</p>\n<p>This estimate on investment portfolio gains comes from Edward Jones analyst James Shanahan who has a Buy rating on the stock.</p>\n<p>Investors will be focused on book value, earnings, and stock repurchases given that CEO Warren Buffett has&nbsp;ramped up the buyback program in recent quarters. The buybacks in the period should total about $6.5 billion, in line with the $6.6 billion in the first quarter.</p>\n<p>This estimate of second-quarter repurchases is based ona filing&nbsp;that Buffett made of his Berkshire holdings in late June after his annual donation of stock to the Bill &amp; Melinda Gates Foundation and other philanthropies.</p>\n<p>The filing showed Buffett’s percentage ownership of Berkshire on June 21 stood at 15.8%.<i>Barron’s</i>calculated a share count for that date based on that figure and compared it with the shares outstanding on March 31 to estimate the buybacks in the second quarter.</p>\n<p>Berkshire’s buybacks have run at about 1% of the shares outstanding a quarter during 2021, with the company valued at about $640 billion.</p>\n<p>Berkshire’s class A shares, which rose 0.3%, to $421,306, on Thursday, have risen almost 21% this year, outpacing the S&amp;P 500 index, which has gained about 18%. Berkshire’s more liquid class B shares rose 0.5%, to $280.21, on&nbsp;Thursday.</p>\n<p>Shanahan of Edward Jones estimates that book value stood at $314,000 per class A shares on June 30, up 7% from the March 31 level. That would mean that Berkshire stock now trades for about 1.3 times its estimated June 30 book value, slightly below the five-year average price/book ratio.</p>\n<p>Berkshire’s earnings growth in the second quarter may have been powered by its largest single unit, Burlington Northern Santa Fe, as well as its many industrial and housing-related businesses. Berkshire’s after-tax operating earnings are expected to increase 10% to $2.51 per class B share, according to FactSet.</p>\n<p>Berkshire owns Clayton Homes, a maker of manufactured housing, Shaw Industries, a producer of carpet and other flooring, and Benjamin Moore, a maker of paints. Burlington Northern’s rival railroad in the western half of the country,Union Pacific(UNP), recently reported a 50% increase in second-quarter operating income relative to the year-earlier period.</p>\n<p>Investors also will be interested to see whether Berkshire was a net buyer of stocks in the second quarter. Buffett has seen limited opportunities in recent quarters, and Berkshire was a net seller of $3 billion of stocks in the first quarter. His biggest purchase in recent quarters has been&nbsp;Verizon Communications(VZ). Berkshire owns about $8 billion of the telecom company.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett’s Berkshire Hathaway Is Reporting Earnings on Saturday. Here’s What to Expect.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett’s Berkshire Hathaway Is Reporting Earnings on Saturday. Here’s What to Expect.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-06 11:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/warren-buffetts-berkshire-hathaway-is-reporting-earnings-on-saturday-heres-what-to-expect-51628176595?mod=hp_DAY_9><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway is expected to report strong second-quarter results on Saturday, including a 7% rise in its book value and a 10% increase in operating earnings.\nBerkshire (ticker: BRK.A and BRK.B) ...</p>\n\n<a href=\"https://www.barrons.com/articles/warren-buffetts-berkshire-hathaway-is-reporting-earnings-on-saturday-heres-what-to-expect-51628176595?mod=hp_DAY_9\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.B":"伯克希尔B","BRK.A":"伯克希尔"},"source_url":"https://www.barrons.com/articles/warren-buffetts-berkshire-hathaway-is-reporting-earnings-on-saturday-heres-what-to-expect-51628176595?mod=hp_DAY_9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196684672","content_text":"Berkshire Hathaway is expected to report strong second-quarter results on Saturday, including a 7% rise in its book value and a 10% increase in operating earnings.\nBerkshire (ticker: BRK.A and BRK.B) likely benefited in the second quarter from a 10% gain in the value of its roughly $300 billion equity portfolio, with about half that appreciation driven by a 12% increase in the share price of Apple (AAPL), Berkshire’s largest equity holding at more than $120 billion.\nThis estimate on investment portfolio gains comes from Edward Jones analyst James Shanahan who has a Buy rating on the stock.\nInvestors will be focused on book value, earnings, and stock repurchases given that CEO Warren Buffett has ramped up the buyback program in recent quarters. The buybacks in the period should total about $6.5 billion, in line with the $6.6 billion in the first quarter.\nThis estimate of second-quarter repurchases is based ona filing that Buffett made of his Berkshire holdings in late June after his annual donation of stock to the Bill & Melinda Gates Foundation and other philanthropies.\nThe filing showed Buffett’s percentage ownership of Berkshire on June 21 stood at 15.8%.Barron’scalculated a share count for that date based on that figure and compared it with the shares outstanding on March 31 to estimate the buybacks in the second quarter.\nBerkshire’s buybacks have run at about 1% of the shares outstanding a quarter during 2021, with the company valued at about $640 billion.\nBerkshire’s class A shares, which rose 0.3%, to $421,306, on Thursday, have risen almost 21% this year, outpacing the S&P 500 index, which has gained about 18%. Berkshire’s more liquid class B shares rose 0.5%, to $280.21, on Thursday.\nShanahan of Edward Jones estimates that book value stood at $314,000 per class A shares on June 30, up 7% from the March 31 level. That would mean that Berkshire stock now trades for about 1.3 times its estimated June 30 book value, slightly below the five-year average price/book ratio.\nBerkshire’s earnings growth in the second quarter may have been powered by its largest single unit, Burlington Northern Santa Fe, as well as its many industrial and housing-related businesses. Berkshire’s after-tax operating earnings are expected to increase 10% to $2.51 per class B share, according to FactSet.\nBerkshire owns Clayton Homes, a maker of manufactured housing, Shaw Industries, a producer of carpet and other flooring, and Benjamin Moore, a maker of paints. Burlington Northern’s rival railroad in the western half of the country,Union Pacific(UNP), recently reported a 50% increase in second-quarter operating income relative to the year-earlier period.\nInvestors also will be interested to see whether Berkshire was a net buyer of stocks in the second quarter. Buffett has seen limited opportunities in recent quarters, and Berkshire was a net seller of $3 billion of stocks in the first quarter. His biggest purchase in recent quarters has been Verizon Communications(VZ). Berkshire owns about $8 billion of the telecom company.","news_type":1},"isVote":1,"tweetType":1,"viewCount":595,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890145695,"gmtCreate":1628088550817,"gmtModify":1633753689786,"author":{"id":"3584848686759477","authorId":"3584848686759477","name":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584848686759477","authorIdStr":"3584848686759477"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890145695","repostId":"1187165636","repostType":4,"isVote":1,"tweetType":1,"viewCount":807,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807439306,"gmtCreate":1628048436905,"gmtModify":1633754045315,"author":{"id":"3584848686759477","authorId":"3584848686759477","name":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584848686759477","authorIdStr":"3584848686759477"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807439306","repostId":"2156312793","repostType":4,"isVote":1,"tweetType":1,"viewCount":606,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807495007,"gmtCreate":1628048050209,"gmtModify":1633754047954,"author":{"id":"3584848686759477","authorId":"3584848686759477","name":"AndrewGoh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584848686759477","authorIdStr":"3584848686759477"},"themes":[],"htmlText":"💪🏾","listText":"💪🏾","text":"💪🏾","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807495007","repostId":"1124757232","repostType":2,"repost":{"id":"1124757232","kind":"news","pubTimestamp":1628045612,"share":"https://www.laohu8.com/m/news/1124757232?lang=&edition=full","pubTime":"2021-08-04 10:53","market":"us","language":"en","title":"3 COVID Stocks That Could Soar Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1124757232","media":"The Motley Fool","summary":"Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfi","content":"<p><b><i>Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.</i></b></p>\n<p><b>Key Points</b></p>\n<ul>\n <li>Pfizer might surprise to the upside.</li>\n <li>Inari Medical is growing like gangbusters.</li>\n <li>Novavax's vaccine might be an important booster shot as the COVID-19 virus mutates.</li>\n</ul>\n<p>COVID-19 and the international lockdown crashed the world economy in 2020. Many people have already been vaccinated and are looking forward to normalization. But COVID is mutating, and the new delta variant might toss a wrench into the world's reopening. How might investors protect themselves?</p>\n<p>A panel of Motley Fool contributors offers three ideas for healthcare stocks that will zoom higher in 2021, even if COVID takes a turn for the worse. Read more to see why you might want to buy shares of&nbsp;<b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b>,&nbsp;<b><a href=\"https://laohu8.com/S/NARI\">Inari Medical, Inc.</a></b>, and&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a></b>.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f3ed6a343e35e121aafbaa2b30134955\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<h3><b>Pfizer: More room to run</b></h3>\n<p><b>George Budwell</b>&nbsp;<b>(Pfizer):</b>&nbsp;American pharma titan Pfizer might not sound like a sexy pick among the present cohort of COVID vaccine players. Wall Street's current consensus has Comirnaty, the drugmaker's vaccine -- produced in partnership with&nbsp;<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;-- losing steam from a sales perspective starting in 2022.</p>\n<p>Because of the delta variant, however, Comirnaty's commercial life could turn out to be much longer than originally expected. And while the emergence of the highly transmissible variant is obviously terrible news for society at large, Pfizer and its shareholders are probably going to benefit from this unfortunate development.</p>\n<p>There are two clear reasons to think that Pfizer's stock could move higher on the delta issue. First and foremost, the company&nbsp;announced&nbsp;that an Emergency Use Authorization submission for a booster third shot might happen as soon as this month. Second, Pfizer plans to start clinical trials for a delta-specific version of the vaccine this month.</p>\n<p>Although the Food and Drug Administration and the Centers for Disease Control and Prevention have both recently downplayed the need for booster shots, Pfizer has already put forth a compelling case for a third jab in response to the rampant spread of the delta variant and the waning efficacy of Comirnaty 6 to 12 months following full vaccination.</p>\n<p>The big picture for investors is that Pfizer's 2022 revenue might jump by as much as 9.7% compared to 2021 -- that is, if a booster shot is indeed approved and the company also successfully develops a delta-specific vaccine. By contrast, Wall Street currently has the drugmaker's top line falling by 14.8% next year relative to 2021.</p>\n<p>Where is Pfizer's stock possibly headed? If all the pieces fall into place on the vaccine front, shares ought to command a $50 handle, from a conservative standpoint. That's roughly a 17% upswing from where the drugmaker's shares presently stand, and that's not even accounting for the company's attractive 3.64% dividend yield at current levels. Put simply, Pfizer's stock would only be trading at approximately 3.5 times 2022 sales if this scenario pans out, which is a rather modest valuation for a&nbsp;dividend-paying&nbsp;big pharma stock.</p>\n<h3><b>Inari Medical: Skyrocketing Sales</b></h3>\n<p><b>Patrick Bafuma</b>&nbsp;<b>(Inari Medical):</b>&nbsp;If you are looking for a stock with staying power after tailwinds from the pandemic subside, look to Inari Medical. There were 108,000 new COVID cases on July 27, 2021 -- the most since February 5, 2021, according to&nbsp;<i>The New York Times</i>&nbsp;-- and that number was up over eight times the seven-day average at the start of July. To make things even worse, COVID not only causes difficulty breathing but also more than triples a patient's risk of disabling and potentially life-threatening blood clots. And we're still not sure if being vaccinated fully mitigates the risk of blood clots when a patient has an asymptomatic or a mild COVID infection.</p>\n<p>This seems like a good setup for a commercial-stage med-tech company that has developed minimally invasive products designed to remove large blood clots without the need for powerful clot-busting drugs. Through the use of its ClotTriever and FlowTriever devices, Inari has treated over 25,000 patients so far. Clinicians performed approximately 5,500 procedures with the company's devices in the first quarter of 2021,&nbsp;up 130% from the same quarter last year&nbsp;and about 20% higher than the fourth quarter of 2020. With about 12% of admitted COVID patients developing blood clots, and about 35,000 COVID hospitalizations in the U.S. (and rising) as of July 27, according to<i>The Times</i>, Inari is likely to see an uptick in eligible cases.</p>\n<p>Not to mention the company's results thus far for blood clots in the lung are spectacular:</p>\n<ul>\n <li>With the historic 30-day mortality rate of intermediate and high-risk blood clots in the lungs at 9.7%, Inari's 0.4% 30-day mortality rate is impressive.</li>\n <li>There's a decreased 30-day readmission rate of 6.7% versus 24.4% with the usual care.</li>\n <li>Major adverse events within 48 hours occur at only a 1.3% rate.</li>\n <li>No ICU stays are required after the procedure.</li>\n</ul>\n<p>Add it all up, and Inari's retrieval device seems like an obvious choice.</p>\n<p>The company grew first-quarter revenue at 113% year over year, and&nbsp;18% sequentially, and had gross margins of 91.9% for the first quarter of 2021. So Inari's price-to-sales ratio of 18 makes it a growth stock on sale.</p>\n<p>Inari has&nbsp;less than 5% penetrationin the $3.8 billion U.S. market, and there's also lots of room to grow in Europe, where it launched earlier this year. That means there are plenty of opportunities for this $4.5-billion market cap company. While COVID has affected many elective and semi-elective procedures, it has clearly not slowed Inari, and it could even accelerate its uptake.</p>\n<h3><b>Novavax: How high can it go?</b></h3>\n<p><b>Taylor Carmichael</b>&nbsp;<b>(Novavax):</b>&nbsp;The vaccine&nbsp;biotech&nbsp;Novavax had an amazing 2020, with its share price running up&nbsp;2,700%&nbsp;on optimism for its COVID vaccine. While the company has yet to file for an Emergency Use Authorization, it expects to do so in this quarter. So far in 2021, the stock is up 60%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0e7829d99a76c48579ba01c6e55fe14f\" tg-width=\"720\" tg-height=\"449\" width=\"100%\" height=\"auto\"><span>NVAX DATA BY YCHARTS.</span></p>\n<p>Positive phase 3 data for the COVID-19 vaccine sent the stock soaring early in the year, but the share price has come back down to earth as the company has suffered delays getting its vaccine to market. First there was a shortage of raw materials necessary to make the vaccine. Now the company has to prove that its various contract manufacturing facilities will keep the vaccine quality consistent across all the sites.</p>\n<p>Despite these delays, long-term investors have reasons to be bullish. Manufacturing is scaling up, with production rates expected to hit 100 million doses a month by the end of the third quarter, and 150 million doses a month by December. While many people in the U.S. have already been vaccinated, the opportunity in the rest of the world is sizable. Novavax has pre-sold 1.1 billion doses to COVAX (an international vaccine consortium), and has contracted to supply hundreds of millions of doses around the world.</p>\n<p>In the U.S., the Novavax vaccine might primarily be used as a&nbsp;booster shot&nbsp;for people who have already been vaccinated. \"They may be really the right ones for boosters,\" Dr. Luciana Borio, the acting chief scientist at the F.D.A. from 2015 to 2017, told&nbsp;<i>The New York Times</i>.</p>\n<p>Down the road, Novavax plans on combining its COVID vaccine with its flu vaccine, making aone-shot regimen. While COVID does not mutate as quickly as the flu, we've seen several mutating strains over the last year. It's likely that we will need to vaccinate more than once in the years ahead.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Could Soar Higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Could Soar Higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 10:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/><strong>The Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfizer might surprise to the upside.\nInari Medical is growing like gangbusters.\nNovavax's vaccine might...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","NARI":"Inari Medical, Inc.","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/08/03/3-covid-stocks-that-will-soar-higher/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124757232","content_text":"Here's why Pfizer, Inari Medical, and Novavax shares might be more valuable in 2021.\nKey Points\n\nPfizer might surprise to the upside.\nInari Medical is growing like gangbusters.\nNovavax's vaccine might be an important booster shot as the COVID-19 virus mutates.\n\nCOVID-19 and the international lockdown crashed the world economy in 2020. Many people have already been vaccinated and are looking forward to normalization. But COVID is mutating, and the new delta variant might toss a wrench into the world's reopening. How might investors protect themselves?\nA panel of Motley Fool contributors offers three ideas for healthcare stocks that will zoom higher in 2021, even if COVID takes a turn for the worse. Read more to see why you might want to buy shares of Pfizer, Inari Medical, Inc., and Novavax.\nIMAGE SOURCE: GETTY IMAGES.\nPfizer: More room to run\nGeorge Budwell (Pfizer): American pharma titan Pfizer might not sound like a sexy pick among the present cohort of COVID vaccine players. Wall Street's current consensus has Comirnaty, the drugmaker's vaccine -- produced in partnership with BioNTech SE -- losing steam from a sales perspective starting in 2022.\nBecause of the delta variant, however, Comirnaty's commercial life could turn out to be much longer than originally expected. And while the emergence of the highly transmissible variant is obviously terrible news for society at large, Pfizer and its shareholders are probably going to benefit from this unfortunate development.\nThere are two clear reasons to think that Pfizer's stock could move higher on the delta issue. First and foremost, the company announced that an Emergency Use Authorization submission for a booster third shot might happen as soon as this month. Second, Pfizer plans to start clinical trials for a delta-specific version of the vaccine this month.\nAlthough the Food and Drug Administration and the Centers for Disease Control and Prevention have both recently downplayed the need for booster shots, Pfizer has already put forth a compelling case for a third jab in response to the rampant spread of the delta variant and the waning efficacy of Comirnaty 6 to 12 months following full vaccination.\nThe big picture for investors is that Pfizer's 2022 revenue might jump by as much as 9.7% compared to 2021 -- that is, if a booster shot is indeed approved and the company also successfully develops a delta-specific vaccine. By contrast, Wall Street currently has the drugmaker's top line falling by 14.8% next year relative to 2021.\nWhere is Pfizer's stock possibly headed? If all the pieces fall into place on the vaccine front, shares ought to command a $50 handle, from a conservative standpoint. That's roughly a 17% upswing from where the drugmaker's shares presently stand, and that's not even accounting for the company's attractive 3.64% dividend yield at current levels. Put simply, Pfizer's stock would only be trading at approximately 3.5 times 2022 sales if this scenario pans out, which is a rather modest valuation for a dividend-paying big pharma stock.\nInari Medical: Skyrocketing Sales\nPatrick Bafuma (Inari Medical): If you are looking for a stock with staying power after tailwinds from the pandemic subside, look to Inari Medical. There were 108,000 new COVID cases on July 27, 2021 -- the most since February 5, 2021, according to The New York Times -- and that number was up over eight times the seven-day average at the start of July. To make things even worse, COVID not only causes difficulty breathing but also more than triples a patient's risk of disabling and potentially life-threatening blood clots. And we're still not sure if being vaccinated fully mitigates the risk of blood clots when a patient has an asymptomatic or a mild COVID infection.\nThis seems like a good setup for a commercial-stage med-tech company that has developed minimally invasive products designed to remove large blood clots without the need for powerful clot-busting drugs. Through the use of its ClotTriever and FlowTriever devices, Inari has treated over 25,000 patients so far. Clinicians performed approximately 5,500 procedures with the company's devices in the first quarter of 2021, up 130% from the same quarter last year and about 20% higher than the fourth quarter of 2020. With about 12% of admitted COVID patients developing blood clots, and about 35,000 COVID hospitalizations in the U.S. (and rising) as of July 27, according toThe Times, Inari is likely to see an uptick in eligible cases.\nNot to mention the company's results thus far for blood clots in the lung are spectacular:\n\nWith the historic 30-day mortality rate of intermediate and high-risk blood clots in the lungs at 9.7%, Inari's 0.4% 30-day mortality rate is impressive.\nThere's a decreased 30-day readmission rate of 6.7% versus 24.4% with the usual care.\nMajor adverse events within 48 hours occur at only a 1.3% rate.\nNo ICU stays are required after the procedure.\n\nAdd it all up, and Inari's retrieval device seems like an obvious choice.\nThe company grew first-quarter revenue at 113% year over year, and 18% sequentially, and had gross margins of 91.9% for the first quarter of 2021. So Inari's price-to-sales ratio of 18 makes it a growth stock on sale.\nInari has less than 5% penetrationin the $3.8 billion U.S. market, and there's also lots of room to grow in Europe, where it launched earlier this year. That means there are plenty of opportunities for this $4.5-billion market cap company. While COVID has affected many elective and semi-elective procedures, it has clearly not slowed Inari, and it could even accelerate its uptake.\nNovavax: How high can it go?\nTaylor Carmichael (Novavax): The vaccine biotech Novavax had an amazing 2020, with its share price running up 2,700% on optimism for its COVID vaccine. While the company has yet to file for an Emergency Use Authorization, it expects to do so in this quarter. So far in 2021, the stock is up 60%.\nNVAX DATA BY YCHARTS.\nPositive phase 3 data for the COVID-19 vaccine sent the stock soaring early in the year, but the share price has come back down to earth as the company has suffered delays getting its vaccine to market. First there was a shortage of raw materials necessary to make the vaccine. Now the company has to prove that its various contract manufacturing facilities will keep the vaccine quality consistent across all the sites.\nDespite these delays, long-term investors have reasons to be bullish. Manufacturing is scaling up, with production rates expected to hit 100 million doses a month by the end of the third quarter, and 150 million doses a month by December. While many people in the U.S. have already been vaccinated, the opportunity in the rest of the world is sizable. Novavax has pre-sold 1.1 billion doses to COVAX (an international vaccine consortium), and has contracted to supply hundreds of millions of doses around the world.\nIn the U.S., the Novavax vaccine might primarily be used as a booster shot for people who have already been vaccinated. \"They may be really the right ones for boosters,\" Dr. Luciana Borio, the acting chief scientist at the F.D.A. from 2015 to 2017, told The New York Times.\nDown the road, Novavax plans on combining its COVID vaccine with its flu vaccine, making aone-shot regimen. While COVID does not mutate as quickly as the flu, we've seen several mutating strains over the last year. It's likely that we will need to vaccinate more than once in the years ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":629,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}